Literature DB >> 2159048

Life span of multipotential hematopoietic stem cells in vivo.

G Keller1, R Snodgrass.   

Abstract

The findings reported in this study highlight several important features of the development of hematopoietic stem cells after transplantation into irradiated recipients. First, they demonstrate the existence of a class of primitive multipotential stem cells that can function for a significant portion of the lifetime of a mouse (15 mo). In addition, they clearly show that these primitive stem cells can be infected with recombinant retroviruses and thus would be appropriate targets for gene therapy in somatic tissues. Second, our data indicate that the progeny of some, but not all, of the primitive stem cells have fully expanded into the various hematopoietic lineages by 2 mo after reconstitution. Finally, our analysis of the secondary recipients provides strong evidence suggesting that the primitive stem cell population can actually clonally expand. Our current experiments are aimed at determining the extent to which this expansion can occur and whether or not this expansion can be influenced by exogenous factors.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2159048      PMCID: PMC2187902          DOI: 10.1084/jem.171.5.1407

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  19 in total

1.  HOW MANY CELL-GENERATIONS?

Authors:  H E KAY
Journal:  Lancet       Date:  1965-08-28       Impact factor: 79.321

2.  Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production.

Authors:  A D Miller; C Buttimore
Journal:  Mol Cell Biol       Date:  1986-08       Impact factor: 4.272

3.  Expression of a foreign gene in myeloid and lymphoid cells derived from multipotent haematopoietic precursors.

Authors:  G Keller; C Paige; E Gilboa; E F Wagner
Journal:  Nature       Date:  1985 Nov 14-20       Impact factor: 49.962

4.  Rapid transfer of DNA from agarose gels to nylon membranes.

Authors:  K C Reed; D A Mann
Journal:  Nucleic Acids Res       Date:  1985-10-25       Impact factor: 16.971

5.  Clonal contributions of small numbers of retrovirally marked hematopoietic stem cells engrafted in unirradiated neonatal W/Wv mice.

Authors:  B Capel; R Hawley; L Covarrubias; T Hawley; B Mintz
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

6.  Expression of v-src induces a myeloproliferative disease in bone-marrow-reconstituted mice.

Authors:  G Keller; E F Wagner
Journal:  Genes Dev       Date:  1989-06       Impact factor: 11.361

7.  A soluble activity from adherent marrow cells cooperates with IL 3 in stimulating growth of pluripotential hematopoietic precursors.

Authors:  N N Iscove; B Fagg; G Keller
Journal:  Blood       Date:  1988-04       Impact factor: 22.113

8.  Number and continuous proliferative pattern of transplanted primitive immunohematopoietic stem cells.

Authors:  D E Harrison; C M Astle; C Lerner
Journal:  Proc Natl Acad Sci U S A       Date:  1988-02       Impact factor: 11.205

9.  Cytological evidence for a relationship between normal hemotopoietic colony-forming cells and cells of the lymphoid system.

Authors:  A M Wu; J E Till; L Siminovitch; E A McCulloch
Journal:  J Exp Med       Date:  1968-03-01       Impact factor: 14.307

10.  Clonal fluctuation within the haematopoietic system of mice reconstituted with retrovirus-infected stem cells.

Authors:  R Snodgrass; G Keller
Journal:  EMBO J       Date:  1987-12-20       Impact factor: 11.598

View more
  47 in total

1.  Previously undetected human hematopoietic cell populations with short-term repopulating activity selectively engraft NOD/SCID-beta2 microglobulin-null mice.

Authors:  H Glimm; W Eisterer; K Lee; J Cashman; T L Holyoake; F Nicolini; L D Shultz; C von Kalle; C J Eaves
Journal:  J Clin Invest       Date:  2001-01       Impact factor: 14.808

2.  The same exhaustible multilineage precursor produces both myeloid and lymphoid cells as early as 3-4 weeks after marrow transplantation.

Authors:  D E Harrison; R K Zhong
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

3.  Proliferation of totipotent hematopoietic stem cells in vitro with retention of long-term competitive in vivo reconstituting ability.

Authors:  C C Fraser; S J Szilvassy; C J Eaves; R K Humphries
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-01       Impact factor: 11.205

4.  Cross species expression analysis of innate immune response.

Authors:  Yong Lu; Roni Rosenfeld; Gerard J Nau; Ziv Bar-Joseph
Journal:  J Comput Biol       Date:  2010-03       Impact factor: 1.479

5.  Clonal analysis of hematopoietic stem-cell differentiation in vivo.

Authors:  L G Smith; I L Weissman; S Heimfeld
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-01       Impact factor: 11.205

6.  The GOD of hematopoietic stem cells: a clonal diversity model of the stem cell compartment.

Authors:  C E Muller-Sieburg; H B Sieburg
Journal:  Cell Cycle       Date:  2006-02-15       Impact factor: 4.534

7.  Isolation and therapeutic potential of human haemopoietic stem cells.

Authors:  Andrew D Clark; Heather G Jørgensen; Joanne Mountford; Tessa L Holyoake
Journal:  Cytotechnology       Date:  2003-03       Impact factor: 2.058

Review 8.  Bloodlines of haematopoietic stem cell research in Japan.

Authors:  Hideo Ema; Hiromitsu Nakauchi
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2008-06-27       Impact factor: 6.237

9.  Self-renewal of primitive human hematopoietic cells (long-term-culture-initiating cells) in vitro and their expansion in defined medium.

Authors:  A L Petzer; D E Hogge; P M Landsdorp; D S Reid; C J Eaves
Journal:  Proc Natl Acad Sci U S A       Date:  1996-02-20       Impact factor: 11.205

10.  Thrombopoietic potential and serial repopulating ability of murine hematopoietic stem cells constitutively expressing interleukin 11.

Authors:  R G Hawley; T S Hawley; A Z Fong; C Quinto; M Collins; J P Leonard; S J Goldman
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-17       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.